salicylazobenzoic acid

used in therapy of ulcerative colitis

Also Known As:

HB 313; Benzoic acid, 5-((4-carboxyphenyl)azo)-2-hydroxy-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/01/1988 - "Benzalazine (salicylazobenzoic acid, SAB), a 5-azo derivative of 5-aminosalicylic acid, has been designed as a new therapeutic agent for the treatment of inflammatory bowel disease which might lack the frequent side effects caused by the sulfapyridine moiety of the sulfasalazine molecule (SASP). "
2.	Ulcerative Colitis 04/24/1982 - "Salicylazobenzoic acid in ulcerative colitis."